Management of raised blood pressure in New Zealand: a discussion document.
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
A report to the National Advisory Committee on Core Health and Disability Support Services, New Zealand, on the management of raised blood pressure recommends that decisions to treat raised blood pressure should be based primarily on the estimated absolute risk of cardiovascular disease rather than on blood pressure alone. In general, patients with a blood pressure of 150-170 mm Hg systolic or 90-100 mm Hg diastolic, or both, should be given treatment to lower blood pressure if the risk of a major cardiovascular disease event in 10 years is more than about 20%. The results of clinical trials indicate that, at this level of absolute risk, 150 people would require treatment to reduce the annual number of cardiovascular events by about one. Implementation of these recommendations may result in a smaller proportion of people aged under 60, particularly women, receiving treatment but an increased proportion of older people treated. In the absence of specific contraindications, low dose diuretics and low dose beta blockers should be considered for first line treatment, since for only these drug groups is there direct evidence of reduced risk of stroke and coronary disease in people with raised blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Self-citationMACMAHON, S. (1990) · The Lancet · doi:10.1016/0140-6736(90)90878-9 · Cited by 4,253
Self-citationAn updated coronary risk profile. A statement for health professionals.
Anderson, K. M., Wilson, P. W., Odell, P. M., & Kannel, W. B. (1991) · Circulation · doi:10.1161/01.cir.83.1.356 · Cited by 1,834
Chobanian, A. V. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380050029006 · Cited by 1,081
BENEFITS AND POTENTIAL HARM OF LOWERING HIGH BLOOD PRESSURE
Cruickshank, J., Thorp, J., & Zacharias, F. J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90231-5 · Cited by 656
Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.
Carlsen, J. E., Køber, L., Torp-Pedersen, C., & Johansen, P. (1990) · BMJ · doi:10.1136/bmj.300.6730.975 · Cited by 269
Physical inactivity as a risk factor for primary and secondary coronary events in Goteborg, Sweden
Johansson, S., Rosengren, A., Tsipogianni, A., Ulvenstam, G., Wiklund, I., & Wilhelmsen, L. (1988) · European Heart Journal · doi:10.1093/eurheartj/9.suppl_l.8 · Cited by 186
The 1993 Guidelines for the Management of Mild Hypertension: Memorandum from a WHO/ISH Meeting
Zanchetti, A., Chalmers, J. P., Arakawa, K., Gyarfas, I., Hamet, P., Hansson, L., Julius, S., MacMahon, S. W., Mancia, G., Ménard, J., et al. (1993) · Blood Pressure · doi:10.3109/08037059309077535 · Cited by 164
Self-citationTHE BETA-BLOCKER POOLING PROJECT RESEARCH GROUP† (1988) · European Heart Journal · doi:10.1093/ehj/9.1.8 · Cited by 156
Cited by
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
“It built on the pioneering work of Jackson and his colleagues, who introduced simple graphical displays of risk as a basis for treatment decisions.(9) A 10-year absolute risk of 20% or more was arbitrarily recommended as a threshold for intensified risk factor intervention.”
Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease
Vasan, R. S., Larson, M. G., Leip, E. P., Evans, J. C., O'Donnell, C. J., Kannel, W. B., & Levy, D. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003417 · Cited by 2,082
Users' Guides to the Medical Literature: IX. A Method for Grading Health Care Recommendations
Guyatt, G. H. (1995) · JAMA · doi:10.1001/jama.1995.03530220066035 · Cited by 846
“Finally, we are more aware that we may serve individual patients or groups of patients best if we withhold treatment for those at very low risk of clinical events while at the same time recommending treatment to those at higher risk [ 12-15 ].”
Background(2014) · The Lancet · doi:10.1016/s0140-6736(14)61212-5 · Cited by 623
Murray, C. J., Lauer, J. A., Hutubessy, R. C., Niessen, L., Tomijima, N., Rodgers, A., Lawes, C. M., & Evans, D. B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12655-4 · Cited by 599
Metadata
- Authors
- Jackson, R., Barham, P., Bills, J., Birch, T., McLennan, L., MacMahon, S., & Maling, T.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1993-07-10
- Volume
- 307
- Issue
- 6896
- Pages
- 107-110
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W1966404458
- Cited by
- 262
- References
- 12
- FWCI
- 16.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of raised blood pressure in New Zealand: a discussion document. https://app.cochat.ai/papers/10.1136/bmj.307.6896.107
- The paper
- Jackson, R., Barham, P., Bills, J., Birch, T., McLennan, L., MacMahon, S., & Maling, T. (1993). Management of raised blood pressure in New Zealand: a discussion document. BMJ. https://doi.org/10.1136/bmj.307.6896.107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.